Whereas paclitaxel treatment induced MDR1 expression in lung cancer cells and subsequently drug efflux, PDLIM2 re-expression was sufficient to block paclitaxel induction of MDR1 and drug efflux (Fig. 5j, k, Supplementary Fig. 8). This evidence concerns the gene PDLIM2 and lung cancer.